Sfoglia per Autore
Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial
2016 M. Özkan, M. Kalçık, M.O. Gürsoy, L. Öcal, S. Griffini, S. Karakoyun, M. Yesin, S. Gündüz, M.A. Astarcıoğlu, E. Bayam, S. Cerşit, A.Ç. Aykan, M. Cugno
Early endothelial damage in patients with raynaud's phenomenon
2017 R. Gualtierotti, F. Ingegnoli, T. Schioppo, S. Griffini, E. Grovetti, M. Borghi, M. Cugno, P. Meroni
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update
2018 G. Ardissino, F. Tel, M. Sgarbanti, D. Cresseri, A. Giussani, S. Griffini, E. Grovetto, I. Possenti, M. Perrone, S. Testa, F. Paglialonga, P. Messa, M. Cugno
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
2019 R. Gualtierotti, F. Ingegnoli, M. Boscolo, S. Griffini, E. Grovetti, M. Cugno
Complement activation in patients with COVID-19: a novel therapeutic target
2020 M. Cugno, P.L. Meroni, R. Gualtierotti, S. Griffini, E. Grovetti, A. Torri, M. Panigada, S. Aliberti, F. Blasi, F. Tedesco, F. Peyvandi
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels
2021 M. Capecchi, E. Scalambrino, S. Griffini, E. Grovetti, M. Clerici, G. Merati, V. Chantarangkul, M. Cugno, F. Peyvandi, A. Tripodi
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome
2021 M. Cugno, S. Berra, F. Depetri, S. Tedeschi, S. Griffini, E. Grovetti, S. Caccia, D. Cresseri, P. Messa, S. Testa, F. Giglio, F. Peyvandi, G. Ardissino
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored Eculizumab
2021 G. Ardissino, D. Cresseri, F. Tel, A. Giussani, S. Salardi, M. Sgarbanti, B. Strumbo, S. Testa, V. Capone, S. Griffini, E. Grovetti, M. Cugno, M. Belingheri, C. Tamburello, E.M. Rodrigues, M. Perrone, M. Cardillo, G. Corti, D. Consonni, L. Furian, S. Tedeschi, P. Messa, C. Beretta
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination
2021 M. Cugno, P. Macor, M. Giordano, M. Manfredi, S. Griffini, E. Grovetti, L. De Maso, S. Mellone, L. Valenti, D. Prati, S. Bonato, G. Comi, A. Artoni, P.L. Meroni, F. Peyvandi
Eculizumab treatment in atypical hemolytic uremic syndrome: correlation between functional complement tests and drug levels
2022 M. Cugno, V. Capone, S. Griffini, E. Grovetti, G. Pintarelli, L. Porcaro, E. Clementi, G. Ardissino
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients
2022 M. Cugno, P.L. Meroni, D. Consonni, S. Griffini, E. Grovetti, C. Novembrino, A. Torri, G. Griffante, M. Gariglio, L. Varani, F. Peyvandi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile